Revenue
attach_money0M USD
YoY -54.3%
VTGNVistaGen Therapeutics, Inc.$ --
VistaGen Therapeutics, Inc.
VTGN
$ -
-
You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.
analyticsIncome Statement Summary
FY2025 Full YearUpdated: 03/31/2025
Operating Income
bar_chart-56M USD
YoY -69.5%
Net Income
verified-51M USD
YoY -75.1%
EPS
pie_chart-1.67USD
YoY -9.9%
Quarterly Performance
Quarterly revenue and net income trend
RevenueOperating IncomeNet Income
No quarterly data available
Full-Year Progress
Net Income Progress98.7%On Track
Revenue Progress805,000
Revenue Forecast1.1M
Net Income Progress-53.4M
Net Income Forecast-54.1M
Income Statement Details
Item
Revenue
Cost of revenue
Gross profit
Research & development
Selling & marketing
Selling, general and administrative
Other operating expenses
Operating income
Interest expense
Income before tax
Income tax expense
Net income
Unlock Long-Term Income Statement Data
Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.